Capstone Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-300
Closed -$21.6K 1846
2024
Q4
$21.6K Hold
300
﹤0.01% 1793
2024
Q3
$24K Buy
+300
New +$22.5K ﹤0.01% 1848
2024
Q2
Sell
-200
Closed -$14.1K 2464
2024
Q1
$14.1K Buy
+200
New +$14.3K ﹤0.01% 2279
2023
Q4
Sell
-600
Closed -$40.8K 2398
2023
Q3
$40.8K Hold
600
﹤0.01% 2032
2023
Q2
$49K Buy
+600
New +$48.2K ﹤0.01% 1766
2022
Q2
Sell
-3,200
Closed -$346K 2109
2022
Q1
$346K Buy
+3,200
New +$330K ﹤0.01% 1566
2021
Q4
Sell
-3,600
Closed -$436K 2084
2021
Q3
$436K Buy
+3,600
New +$438K ﹤0.01% 1591

Other funds holding TECH

Capstone Investment Advisors's TECH Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 32,781 shares — an estimated $1.82M sold.

Capstone Investment Advisors first reported a position in TECH in Q4 2016 and held it in 9 quarters. The position peaked at $1.82M in Q3 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 32,781 Bio-Techne shares in Q4 2025, an estimated $1.82M.
  • Capstone Investment Advisors first reported a position in Bio-Techne in Q4 2016 and held it in 9 quarters.
  • Capstone Investment Advisors's Bio-Techne position peaked at $1.82M in Q3 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.